News

Professor Hirohide Saito and his research team have developed a new microRNA-responsive hybrid mRNA switch, enabling precise, ...
Researchers from Tel Aviv University and the Israel Institute for Biological Research in Ness Ziona have used the platform ...
The mRNA therapeutics field is rapidly evolving beyond vaccines to include treatments for cancer, genetic disorders and in vivo cell therapies, bringing with it diverse production challenges. As the ...
RNA Victoria funds 2 Florey projects to prevent and treat Alzheimer's diseaseKey points mRNA Victoria has funded 2 Alzheimer's disease research ...
Professor Hirohide Saito (Department of Life Science Frontiers at CiRA / The University of Tokyo) and Assistant Professor ...
The Hong Kong-listed firm is advancing its pipeline using an mRNA system it says can compete with the industry’s best.
To build proteins, cells rely on a molecule called transfer RNA, or tRNA. tRNAs act like protein-building couriers, where ...
A Pennsylvania Representative is looking to ban testing mRNA vaccines on domestic animals. Representative Jacob Banta (R-Erie ...
Researchers develop a self-regulating mRNA medicine that adjusts protein production based on disease-related signals.
DelveInsight's, “Melanoma Pipeline Insight” report provides comprehensive insights about 150+ companies and 170+ pipeline ...
The mRNA molecule is too large to pass through a cell membrane by free diffusion and carries multiple negative charges, increasing the difficulty of their delivery.